Simo International's 2022 Performance Report Release

Mar.21.2023

Semiconductor company Smore International released its 2022 performance report, showing decreased revenue and net profit.

On March 20th at 10:58 PM, SMIC International released their performance report for 2022. According to the report, their revenue for the year was 12.145 billion yuan, a decrease of 11.7% from the previous year. After adjustments, their net profit for the year was 2.575 billion yuan, a decrease of 52.7% from the previous year.

Financial Report Data of SMOR | Source: SMOR

According to the financial report, one of the reasons for Simoer's decrease in revenue is:

The US electronic vaporizer market has experienced a temporary negative impact on overall sales growth for compliant products due to non-compliant products in the market. In order to support certain customers and increase market share, prices for certain products have been reduced. In terms of specialized vaporizer products, macroeconomic factors such as inflation have led to a temporary decline in sales of vaporizer components. However, in their financial report, the company expressed confidence in the future competitiveness of their products in the group and the long-term growth of the US market, as the enforcement efforts of the FDA continue to strengthen.

According to Smoore's financial report, medical nebulization is poised to become the company's next growth curve. The company has formally established the American Pharmaceutical Research Institute and formed a team for inhaled medicine research and development. This research institute is dedicated to developing new types of inhaled drugs for targeted treatment of respiratory and other challenging diseases.

As of 11:15am on March 21st, semiconductor company SMIC's stock price on the Hong Kong Stock Exchange has increased by over 7%, reaching HKD 10.20 per share.

Somor Stock | Source: Hong Kong Stock Exchange

Stay tuned for our analysis of the Somer annual report coming soon. Keep an eye out.

References:

Performance Report for the Fiscal Year Ending December 31, 2022

#Europe #Traditional tobacco #Legislation #Alemania #Report

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Philippine DOH Calls for Nationwide Vape Ban Amid Surging Youth Use

The Philippine Department of Health (DOH) has warned that youth vaping has reached alarming levels. Health Secretary Ted Herbosa stressed that despite regulations limiting vaping to adults aged 18 and above, minors—many in school uniforms—are frequently seen using vape devices. Criticizing the industry’s youth-targeted marketing tactics, Herbosa said the government should consider a nationwide total ban on vape products.

Nov.24 by 2FIRSTS.ai

Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model

The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.

Regulations

Dec.20

U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned

Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.

Nov.06 by 2FIRSTS.ai

The Spanish Nicotine Pouches Association (ABN) is officially launched, calling for a clear regulatory framework grounded in scientific evidence

The Spanish Nicotine Pouches Association (ABN) has launched in Madrid, uniting more than 40 companies to call for science-based, proportionate regulation. The group warns that a proposed 0.99 mg nicotine cap could amount to a de facto ban and introduces new voluntary industry standards in response.